Details

Last Funding Type

Series A

Last Funding Money Raised

$7.50M

Industries

Biotechnology,Information Technology,Manufacturing,Semiconductor

Founded date

Jan 1, 2013

Number Of Employee

11 - 50

Operating Status

Active

Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors. Cardean transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with direct electrical molecular signal analysis. With Cardean transistors, the company and its Innovation Partners can generate streaming multi-omics data to measure real-time biological signals. Cardea is now manufacturing chips at scale and partners have started to significantly expand the amount, type, and quality of biological data they capture by building products that Conduct Biolog.